Back

Electrical heart failure treatment in the Goldilocks zone: cardiac contractility modulation proves equally effective for heart failure control in HFrEF patients with mid-range QRS durations

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Electrical therapy in heart failure: what's new? Devices for Autonomic Modulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Christian Fastner

University Medical Centre Mannheim, Mannheim (Germany)

6 More presentations in this session

Presentation thumbnail
Clinical phenotypes in relation to outcomes in heart failure patients with cardiac resynchronization therapy and defibrillators (CRT-D): an unsupervised cluster analysis
Doctor L. Gerra (Piacenza, IT)
Abstract Slides Video
Presentation thumbnail
Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up
Doctor D. Wang (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
QRS complex fragmentation status before and after cardiac resynchronization therapy predicts hospitalizations for heart failure
Doctor C. Rodriguez-Lopez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Impact of left ventricular lead position on echocardiographic response after upgrading from right to biventricular pacing - Insights from the BUDAPEST CRT Upgrade Trial
Professor B. Merkely (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmia characteristics after left ventricular assist device implantation
Doctor X. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Electrical therapy in heart failure: what's new?

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Welcome and introduction
thumbnail
Congress Presentation
Predict-CCM: an italian multicenter study to assess the predictive value of dobutamine echo-stress in the clinical response to cardiac contractility modulation therapy (CCM)
thumbnail
Congress Session
Reducing hospitalisations and improving quality of life: why use cardiac contractility modulation (CCM)?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources